Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Anosmia × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 Plasma cell 1 Other 1 Lymphoid 1 Genitourinary 1

Conditions

Multiple Myeloma 1905 Neoplasms, Plasma Cell 448 Lymphoma 316 Lymphoma, Non-Hodgkin 304 Hodgkin Disease 292 Leukemia, Lymphocytic, Chronic, B-Cell 274 Precursor Cell Lymphoblastic Leukemia-Lymphoma 267 Leukemia 262 Leukemia, Myeloid, Acute 239 Myelodysplastic Syndromes 237 Lymphoma, Mantle-Cell 204 Lymphoma, Follicular 198 Lymphoma, Large B-Cell, Diffuse 192 Lymphoma, B-Cell, Marginal Zone 181 Burkitt Lymphoma 179 Myeloproliferative Disorders 165 Recurrence 163 Lymphoma, Large-Cell, Immunoblastic 163 Immunoglobulin Light-chain Amyloidosis 142 Primary Myelofibrosis 139 Leukemia, Myeloid, Chronic-Phase 133 Leukemia, Myeloid, Accelerated Phase 128 Lymphoma, T-Cell, Cutaneous 126 Leukemia, Myelomonocytic, Chronic 121 Blast Crisis 119 Mycosis Fungoides 111 Sezary Syndrome 110 Waldenstrom Macroglobulinemia 105 Congenital Abnormalities 104 Leukemia, Hairy Cell 100

Interventions

Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04716153 2026-01-20

RE-NEZ-SENS

University Hospital, Montpellier

Phase NA Terminated

LymphoidPlasma cell

Anosmia, Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡